Candesartan Cilexetil And Hydrochlorothiazide Tablet
Product Images NDC 33342-131

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Candesartan Cilexetil And Hydrochlorothiazide (NDC 33342-131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

16-12.5-100s (16 12.5 100s)

Packaging label for Candesartan Cilexetil and Hydrochlorothiazide Tablets 16 mg/12.5 mg by Macleods Pharmaceuticals Limited. The label displays the dosage strength, tablet count of 100 tablets in unit dose blister cards, and storage instructions. Manufactured for Macleods Pharma USA, Inc., Plainsboro, NJ, the label includes barcodes, batch and expiration date fields, and dosage information.*

FDA Label Image

16-12.5mg-300s (16 12.5mg 300s)

Label for Candesartan Cilexetil and Hydrochlorothiazide Tablets, 16 mg/12.5 mg, oral dosage form. The label states the product contains 300 tablets and is manufactured by Macleods Pharmaceuticals Ltd., India, for Macleods Pharma USA, Inc. It includes storage instructions and dosage directions to refer to prescribing information. The label displays the NDC 33342-131-51 and features barcodes.*

FDA Label Image

32-12.5-100s (32 12.5 100s)

Packaging label for Candesartan Cilexetil and Hydrochlorothiazide Tablets, 32 mg / 12.5 mg, oral tablets. The label shows a 100 tablet (10 x 10) unit dose pack produced by Macleods Pharmaceuticals Ltd and Macleods Pharma USA. The label includes dosage strength, manufacturer information, storage instructions, and states the blister cards are not child resistant.*

FDA Label Image

32-12.5-300s (32 12.5 300s)

Label for Candesartan Cilexetil and Hydrochlorothiazide Tablets, 32 mg/12.5 mg strength, oral tablet dosage form. The label shows it is manufactured by Macleods Pharmaceuticals Ltd. and labeled by Macleods Pharma USA, Inc. It includes storage instructions, dosage directions reference, NDC 33342-132-51, and a count of 300 tablets.*

FDA Label Image

32-25-100s (32 25 100s)

Label for Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/25 mg by Macleods Pharmaceuticals Limited. The oral tablet packaging displays the dosage strength prominently in green highlights, with 100 tablets (10 x 10 unit dose tablets) per package. The label includes manufacturing and storage information along with dosage details.*

FDA Label Image

32-25-300s (32 25 300s)

Label for Candesartan Cilexetil and Hydrochlorothiazide Tablets, 32 mg/25 mg strength, oral tablet dosage form. The label indicates a quantity of 300 tablets and is manufactured by Macleods Pharmaceuticals Limited, India, for Macleods Pharma USA, Inc. Storage and dosage instructions are included along with barcodes and an NDC number 33342-133-51.*

FDA Label Image

Cande (Candesartan Hctz 16 12 5 500s)

Packaging label for Candesartan Cilexetil and Hydrochlorothiazide Tablets, 16 mg/12.5 mg strength. The label shows a quantity of 500 tablets and indicates oral dosage form. Manufactured by Macleods Pharmaceuticals Limited and Macleods Pharma USA, Inc. Storage instructions and dosing information references are included on the label.*

FDA Label Image

Cande (Candesartan Hctz 16 12 5 90s)

Label for Candesartan Cilexetil and Hydrochlorothiazide tablets, 16 mg/12.5 mg strength, supplied in a package containing 90 oral tablets. The label includes barcodes, manufacturer information for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd., as well as storage instructions and space for batch number and expiration date.*

FDA Label Image

Cande (Candesartan Hctz 32 12 5 500s)

Label for Candesartan Cilexetil and Hydrochlorothiazide tablets, 32 mg/12.5 mg strength. The label states the product is marketed by Macleods Pharma USA and manufactured by Macleods Pharmaceuticals Ltd., India. The bottle contains 500 tablets and includes storage instructions and dosage reminder to see prescribing information.*

FDA Label Image

Cande (Candesartan Hctz 32 12 5 90s)

Label for Candesartan Cilexetil and Hydrochlorothiazide Tablets 32 mg/12.5 mg by Macleods Pharmaceuticals Limited. The label indicates the product contains 90 tablets and is for prescription use only. It includes storage instructions and manufacturer details for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd., India.*

FDA Label Image

Cande (Candesartan Hctz 32 25 500s)

Label for Candesartan Cilexetil and Hydrochlorothiazide Tablets, strength 32 mg/25 mg, manufactured by Macleods Pharmaceuticals Limited. The label states 500 tablets, with prescription use only, listing the active ingredients as 32 mg Candesartan Cilexetil and 25 mg Hydrochlorothiazide per tablet. Storage instructions and batch information areas are also visible.*

FDA Label Image

Cande (Candesartan Hctz 32 25 90s)

Label for Candesartan Cilexetil and Hydrochlorothiazide Tablets, 32 mg/25 mg, with 90 tablets in the package. The label indicates it is manufactured by Macleods Pharmaceuticals Limited and Macleods Pharma USA, Inc. It includes storage instructions and dosage guidance notes, along with barcodes and product identification numbers.*

FDA Label Image

Cande-structure (Candesartan Structure)

Chemical structure diagram of the active ingredient Candesartan Cilexetil, showing its molecular bonds and highlighting the site of ester hydrolysis.*

FDA Label Image

Hctz-structure (Hydrochlorothiazide Structure)

Chemical structure of the active ingredient Candesartan Cilexetil, showing its molecular arrangement with labeled atoms including chlorine, sulfur, oxygen, nitrogen, and attached functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.